Immune Responses and Pathogenesis following Experimental SARS-CoV-2 Infection in Domestic Cats

Описание

Тип публикации: статья из журнала

Год издания: 2023

Идентификатор DOI: 10.3390/v15051052

Аннотация: <jats:p>Several reports demonstrated the susceptibility of domestic cats to SARS-CoV-2 infection. Here, we describe a thorough investigation of the immune responses in cats after experimental SARS-CoV-2 inoculation, along with the characterization of infection kinetics and pathological lesions. Specific pathogen-free domestic cats Показать полностью(n = 12) were intranasally inoculated with SARS-CoV-2 and subsequently sacrificed on DPI (days post-inoculation) 2, 4, 7 and 14. None of the infected cats developed clinical signs. Only mild histopathologic lung changes associated with virus antigen expression were observed mainly on DPI 4 and 7. Viral RNA was present until DPI 7, predominantly in nasal and throat swabs. The infectious virus could be isolated from the nose, trachea and lungs until DPI 7. In the swab samples, no biologically relevant SARS-CoV-2 mutations were observed over time. From DPI 7 onwards, all cats developed a humoral immune response. The cellular immune responses were limited to DPI 7. Cats showed an increase in CD8+ cells, and the subsequent RNA sequence analysis of CD4+ and CD8+ subsets revealed a prominent upregulation of antiviral and inflammatory genes on DPI 2. In conclusion, infected domestic cats developed a strong antiviral response and cleared the virus within the first week after infection without overt clinical signs and relevant virus mutations.</jats:p>

Ссылки на полный текст

Издание

Журнал: Viruses

Выпуск журнала: Т. 15, 5

Номера страниц: 1052

ISSN журнала: 19994915

Персоны

  • Vreman Sandra (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • van der Heijden Elisabeth M. D. L. (Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands)
  • Ravesloot Lars (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Ludwig Irene S. (Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands)
  • van den Brand Judith M. A. (Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands)
  • Harders Frank (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Kampfraath Andries A. (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Egberink Herman F. (Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands)
  • Gonzales Jose L. (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Oreshkova Nadia (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Broere Femke (Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands)
  • van der Poel Wim H. M. (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)
  • Gerhards Nora M. (Wageningen Bioveterinary Research, Wageningen University &amp; Research, 8221 RA Lelystad, The Netherlands)

Вхождение в базы данных